Development of paclitaxel-loaded liposomal nanocarrier stabilized by triglyceride incorporation

References

• GoldspielBRClinical overview of the taxanesPharmacotherapy1997175 Pt 2110s125s9322878
   PubMed Web of Science ®Google Scholar
• RowinskyEKEisenhauerEAChaudhryVArbuckSGDonehowerRCClinical toxicities encountered with paclitaxel (Taxol)Semin Oncol1993204 Suppl 31158102012
   PubMed Web of Science ®Google Scholar
• FjällskogMLFriiLBerghJIs Cremophor EL, solvent for paclitaxel, cytotoxic?Lancet199334288758738104306
   PubMed Web of Science ®Google Scholar
• DorrRTPharmacology and toxicology of Cremophor EL diluentAnn Pharmacother1994285 SupplS11S147915152
   PubMedGoogle Scholar
• YangTCuiFDChoiMKLiposome formulation of paclitaxel with enhanced solubility and stabilityDrug Deliv200714530130817613018
   PubMed Web of Science ®Google Scholar
• StinchcombeTENanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxelNanomedicine (Lond)20072441542317716129
   PubMed Web of Science ®Google Scholar
• ClineENLiMHChoiSKPaclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of actionBiomacromolecules201314365466423391096
   PubMed Web of Science ®Google Scholar
• DanhierFLecouturierNVromanBPaclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluationJ Control Release20091331111718950666
   PubMed Web of Science ®Google Scholar
• KimTYKimDWChungJYPhase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignanciesClin Cancer Res200410113708371615173077
   PubMed Web of Science ®Google Scholar
• GreenMRManikhasGMOrlovSAbraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancerAnn Oncol20061781263126816740598
   PubMed Web of Science ®Google Scholar
• YangTCuiFDChoiMKEnhanced solubility and stability of PEGylated liposomal paclitaxel: in vitro and in vivo evaluationInt J Pharm20073381–231732617368984
   PubMed Web of Science ®Google Scholar
• SenKMandalMSecond generation liposomal cancer therapeutics: transition from laboratory to clinicInt J Pharm20134481284323500602
   PubMedGoogle Scholar
• ZhangJAAnyarambhatlaGMaLDevelopment and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulationEur J Pharm Biopharm200559117718715567316
   PubMed Web of Science ®Google Scholar
• SharmaAStraubingerRMNovel taxol formulations: preparation and characterization of taxol-containing liposomesPharm Res19941168898967937531
   PubMed Web of Science ®Google Scholar
• KanPTsaoCWWangAJSuWCLiangHFA liposomal formulation able to incorporate a high content of paclitaxel and exert promising anticancer effectJ Drug Deliv2011201162923421490755
   PubMedGoogle Scholar
• KannanVBalabathulaPDiviMKThomaLAWoodGCOptimization of drug loading to improve physical stability of paclitaxel-loaded long-circulating liposomesJ Liposome Res201525430831525541107
   PubMed Web of Science ®Google Scholar
• KoudelkaSTuranek-KnotigovaPMasekJLiposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effectJ Pharm Sci20109952309231919904827
   PubMedGoogle Scholar
• CrosassoPCerutiMBrusaPArpiccoSDosioFCattelLPreparation, characterization and properties of sterically stabilized paclitaxel-containing liposomesJ Control Release2000631–2193010640577
   PubMed Web of Science ®Google Scholar
• ImmordinoMLBrusaPArpiccoSStellaBDosioFCattelLPreparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxelJ Control Release200391341742912932719
   PubMed Web of Science ®Google Scholar
• YeLHeJHuZAntitumor effect and toxicity of Lipusu in rat ovarian cancer xenograftsFood Chem Toxicol20135220020623149094
   PubMed Web of Science ®Google Scholar
• SlingerlandMGuchelaarHJRosingHBioequivalence of liposome-entrapped paclitaxel easy-to-use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancerClin Ther201335121946195424290734
   PubMedGoogle Scholar
• FasolUFrostABuchertMVascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasisAnn Oncol20122341030103621693769
   PubMed Web of Science ®Google Scholar
• MattjusPSlotteJPDoes cholesterol discriminate between sphingo-myelin and phosphatidylcholine in mixed monolayers containing both phospholipids?Chem Phys Lipids199681169809450320
   PubMedGoogle Scholar
• PaytonNMWempeMFBetkerJLRandolphTWAnchordoquyTJLyophilization of a triply unsaturated phospholipid: effects of trace metal contaminantsEur J Pharm Biopharm201385230631323567484
   PubMedGoogle Scholar
• LehtonenJYKinnunenPKPoly(ethylene glycol)-induced and temperature-dependent phase separation in fluid binary phospholipid membranesBiophys J19956825255357696506
   PubMedGoogle Scholar
• HongRLHuangCJTsengYLDirect comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?Clin Cancer Res19995113645365210589782
   PubMed Web of Science ®Google Scholar
• HongSSKimSHLimSJEffects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomesInt J Pharm20154831–214215025667981
   PubMedGoogle Scholar
• HongS-SLimS-JLaboratory scale production of injectable liposomes by using cell disruptor to avoid the probe sonication processJ Pharm Investig20154517378
   Google Scholar
• KangDILeeSLeeJTPreparation and in vitro evaluation of anti-VCAM-1-Fab’-conjugated liposomes for the targeted delivery of the poorly water-soluble drug celecoxibJ Microencapsul201128322022721425947
   PubMed Web of Science ®Google Scholar
• LeeEHHongSSKimSHLeeMKLimJSLimSJComputed tomography-guided screening of surfactant effect on blood circulation time of emulsions: application to the design of an emulsion formulation for paclitaxelPharm Res20143182022203424549824
   PubMedGoogle Scholar
• KangSNHongSSLeeMKLimSJDual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxibInt J Pharm20124281–2768122405988
   PubMedGoogle Scholar
• KimSKimJYHuhKMAcharyaGParkKHydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxelJ Control Release2008132322222918672013
   PubMed Web of Science ®Google Scholar
• LimSJLeeMKKimCKAltered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powdersJ Control Release20041001536115491810
   PubMed Web of Science ®Google Scholar
• LiangHYangQDengLLuJChenJPhospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxelDrug Dev Ind Pharm201137559760521469948
   PubMed Web of Science ®Google Scholar
• RombergBOussorenCSnelCJHenninkWEStormGEffect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)sPharm Res200724122394240117674159
   PubMed Web of Science ®Google Scholar
• HinrichsWLMancenidoFASandersNNThe choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze dryingInt J Pharm20063111–223724416442758
   PubMed Web of Science ®Google Scholar
• CampbellRBBalasubramanianSVStraubingerRMInfluence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomesJ Pharm Sci20019081091110511536214
   PubMedGoogle Scholar
• MullerRHHeinemannSFat emulsions for parenteral nutrition. I: evaluation of microscopic and laser light scattering methods for the determination of the physical stabilityClin Nutr199211422323616840001
   PubMedGoogle Scholar
• KannanVBalabathulaPThomaLAWoodGCEffect of sucrose as a lyoprotectant on the integrity of paclitaxel-loaded liposomes during lyophilizationJ Liposome Res201525427027825534990
   PubMed Web of Science ®Google Scholar
• LuJChuanXZhangHFree paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivoInt J Pharm20144711–252553524858391
   PubMed Web of Science ®Google Scholar
• LiuFParkJYZhangYTargeted cancer therapy with novel high drug-loading nanocrystalsJ Pharm Sci20109983542355120564383
   PubMed Web of Science ®Google Scholar
• TangBFangGGaoYLiprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: in vitro characterization and in vivo evaluationInt J Pharm20144751–241642725218393
   PubMedGoogle Scholar
• HarisaGINaringin mitigates erythrocytes aging induced by paclitaxel: an in vitro studyJ Biochem Mol Toxicol201428312913624375949
   PubMedGoogle Scholar